MELODY study
The study aims to recruit people who have received solid organ transplants, people with rare autoimmune diseases receiving immunosuppression and people who have had a diagnosis of blood cancer.
#MELODYStudy Mass evaluation of lateral flow immunoassays for the detection of SARS-CoV-2 antibody responses in immunosuppressed people
Open NOW to all patients with solidorgan transplants: please register here melodystudy.org we need you!
The study, known as ‘MELODY’, will involve 36,000 immunocompromised patients across the UK, starting with those with kidney and other organ transplants, and then later including patients with cancer and #autoimmune diseases.